[1]
Apert M. E.: De l’acrocephalosyndactylie. Bull Mem Soc Med Hop 1906;
23: 1310–1330.
[2]
Cohen M. M., Kreiborg S.: Hands and feet in the Apert syndrome. Am J
Med Genet 1995; 57: 82–96.
[3]
Wilkie A. O. M., Slaney S. F., Oldridge M., et al.: Apert syndrome results
from localized mutations of FGFR2 and is allelic with Crouzon syndrome.
Nature Genet 1995; 9: 165–172.
[4]
Moloney D. M., Slaney S. F., Oldridge M., et al.: Exclusive paternal origin
of new mutations in Apert syndrome. Nature Genet 1996; 13: 48–53.
[5]
Cohen M. M., Kreiborg S., Lammer E. J., et al.: Birth prevalence study of
the Apert syndrome. Am J Med Genet 1992; 42: 655–659.
[6]
Mantilla-Capacho J. M., Arnaud L., Diaz-Rodriguez M., et al.: Apert
syndrome with preaxial polydactyly showing the typical mutation
Ser252Trp in the FGFR2 gene. Genet Counsel 2005; 16: 403–406.
[7]
Patton M. A., Goodship J., Hayward R., et al.: Intellectual development
in Apert’s syndrome: a long term follow up of 29 patients. J Med Genet
1988; 25: 164–167.
[8]
Quintero-Rivera F., Robson C. D., Reiss R. E., et al.: Intracranial anomalies
detected by imaging studies in 30 patients with Apert syndrome. (Letter)
Am J Med Genet 2006; 140A: 1337-1338.
[9]
Cohen M.M.: Apert Sydrome. [w:] Craniosynostosis. Diagnosis,
evaluation and management. Cohen M.M., MacLean R.E. [red], Oxford
University Press, New York, Oxford 2000.
[10]
Wocjan J.: Neurochirurgia dziecięca – zagadnienia wybrane. [w:]
Neurologia Dziecięca. Michałowicz R., Jóźwiak S. [red.], Urban & Partner, Wrocław 2000.
[11]
Johnson D. and Andrew A. O.: Cranisynostosis. Eur J Hum Genet 2011;
19: 369–376.
[12]
Kreiborg S., Cohen M.M. Jr.: Ocular manifestations of Apert and Crouzon
syndromes: qualitative and quantitative findings. J Craniofac Surg 2010;
21: 1354–1357.
[13]
Allam K.A., Wan D.C., Khwanngern K., et al.: Treatment of Apert
syndrome: a long-term follow-up study. Plast Reconstr Surg 2011; 127:
1601–1611.
[14]
Oberoi S., Hoffman W.Y., Vargervik K.: Craniofacial team management in
Apert syndrome. Am J Orthod Dentofacial Orthop 2012; 141: 82–87.
[15]
Goriely A., McVean G.A., van Pelt A.M., et al.: Gain-of-function amino
acid substitutions drive positive selection of FGFR2 mutations in human
spermatogonia. Proc Natl Acad Sci U S A 2005; 26: 6051–6056.
Scholar Google
PubMed